Discrepancy between genetically predicted and observed BMI predicts incident type 2 diabetes
Rhee TM, Choi J, Lee H, et al.
Diabetes Care. Pub. Online 13 Aug 2024.
Leggi
Breaking news
Kidney and cardiovascular effectiveness of SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes
Edmonston D, Mulder H, Lydon E, et al.
J Am Coll Cardiol. Pub. Online 20 Aug 2024.
Leggi
Association of ultra-processed food consumption with risk of microvascular complications among individuals with type 2 diabetes in the UK Biobank: a prospective cohort study
Li Y, Lai Y, Geng T, et al.
Am J Clin Nutr. Pub. online 25 Jul 2024.
Leggi
Association of semaglutide with tobacco use disorder in patients with type 2 diabetes: target trial emulation using real-world data
Wang W, Volkow ND, Berger NA, et al.
Ann Intern Med. Pub. online 30 Jul 2024.
Leggi
FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products
26/07/2024
Leggi
MiniMed 780G system use in type 1 diabetes during Ramadan intermittent fasting: a systematic literature review and expert recommendations
Elbarbary NS, Alguwaihes A, Zarif H, et al.
Diabetes Technol Ther. Pub. online 25 Jul 2024.
Leggi
Body weight change associated kidney outcomes of sodium-glucose cotransporter new users
Jimba T, Kaneko H, Azegami T, et al.
Diabetes Obes Metab. Pub. online 28 Jul 2024.
Leggi
Follow-up and monitoring programme in children identified in early-stage type 1 diabetes during screening in the general population of Italy
Cherubini V, Mozzillo E, Iafusco D, et al.
Diabetes Obes Metab. Pub. online 26 Jul 2024.
Leggi
Frequency of rebound hyperglycemia in adults with type 1 diabetes treated with different insulin delivery modalities
Tidemand KG, Laugesen C, Ranjan A, et al.
Diabetes Technol Ther. Pub. online 25 Jul 2024.
Leggi